AVGO vs AWRE

Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 3/9, indicating significant operational and profitability concerns. Despite strong gross margins and robust year-over-year revenue growth of 33.3%, the company continues to report negative profit and operating margins, resulting in negative ROE and ROA. The absence of an Altman Z-Score prevents a full distress risk assessment, but the current negative earnings and lack of valuation metrics suggest elevated risk. While insider sentiment is moderately positive at 60/100, technical trend signals are bearish, and recent price performance shows deterioration over the medium term.